Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Bone Neoplasms × Clear all

Phase

Phase NA 12 Phase 2 9 Phase 3 4 Phase 1 3 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 38 Neoplasms 31 Carcinoma, Non-Small-Cell Lung 23 Prostatic Neoplasms 21 Polycystic Ovary Syndrome 14 Pain 14 Leukemia 12 Keratosis, Actinic 11 Carcinoma, Hepatocellular 10 Uterine Cervical Neoplasms 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Leiomyoma 9 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Brain Neoplasms 9 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Melanoma 7 Lymphoma, Follicular 7 Head and Neck Neoplasms 7 Arthritis, Rheumatoid 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroendocrine Tumors 6 Lymphoma 6 Liver Neoplasms 6 Leukemia, Myeloid, Acute 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Kidney Neoplasms 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡